Codes / ICD10CM / D89.44

D89.44 Hereditary alpha tryptasemia

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Hereditary alpha tryptasemia

Summary

Hereditary alpha tryptasemia is a genetic condition characterized by elevated baseline serum tryptase levels, often due to increased copy numbers of the TPSAB1 gene. This can lead to a spectrum of symptoms, including allergic-like reactions, mast cell-related symptoms, and potential organ involvement. The condition is typically inherited in an autosomal dominant pattern and may present with variable expressivity, meaning symptoms can range from mild to severe among affected individuals.

Causes

Hereditary alpha tryptasemia is caused by genetic variations, specifically increased copy numbers of the TPSAB1 gene, which encodes alpha tryptase. This genetic alteration results in elevated baseline serum tryptase levels. The condition is inherited in an autosomal dominant manner, meaning a single copy of the altered gene from a parent can lead to the condition. The exact mechanism by which increased gene copies cause elevated tryptase and associated symptoms is still under investigation, but it is thought to involve dysregulation of mast cell function.

Risk Factors

  • Family history of elevated tryptase levels or related symptoms
  • Inheritance of the TPSAB1 gene duplication
  • Personal or family history of allergic or mast cell-related disorders
  • Exposure to environmental triggers that may exacerbate symptoms (e.g., certain foods, medications, or physical stimuli)

Symptoms

  • Elevated baseline serum tryptase levels (often >20 ng/mL)
  • Allergic-like reactions (e.g., urticaria, angioedema)
  • Gastrointestinal symptoms (e.g., abdominal pain, nausea, diarrhea)
  • Respiratory symptoms (e.g., wheezing, shortness of breath)
  • Skin manifestations (e.g., flushing, rashes)
  • Potential for organ involvement (e.g., cardiovascular, neurological)

Diagnosis

Diagnosis of hereditary alpha tryptasemia involves measuring baseline serum tryptase levels, typically performed when the patient is asymptomatic. Levels above 20 ng/mL on two separate occasions are suggestive. Genetic testing for TPSAB1 gene copy number analysis confirms the diagnosis. Clinical evaluation includes assessing for symptoms and ruling out other causes of elevated tryptase, such as clonal mast cell disorders or allergic reactions. Family history and genetic counseling may also be considered.

Treatment Options

Treatment focuses on managing symptoms and avoiding triggers. Antihistamines, mast cell stabilizers, or leukotriene modifiers may be used to control allergic or mast cell-related symptoms. In severe cases, epinephrine or other emergency medications may be necessary for acute reactions. Individualized care plans are developed based on symptom severity and organ involvement. Regular monitoring of tryptase levels and symptom management is key.

Prognosis and Follow-Up

The prognosis for hereditary alpha tryptasemia varies, with many individuals experiencing mild symptoms or remaining asymptomatic. Regular follow-up is important to monitor for symptom changes or new manifestations. Long-term management may involve periodic tryptase level checks and adjustments to treatment plans. Early diagnosis and symptom control can improve quality of life, though the condition is chronic and requires ongoing care.

Complications

Potential complications include severe allergic reactions, organ dysfunction (e.g., cardiovascular, gastrointestinal), and reduced quality of life due to chronic symptoms. Rarely, the condition may be associated with an increased risk of anaphylaxis or other mast cell-related disorders. Close monitoring and prompt treatment of symptoms can help mitigate these risks.

Lifestyle & Prevention

Lifestyle modifications may include identifying and avoiding known triggers (e.g., certain foods, medications, or environmental factors) that exacerbate symptoms. Maintaining a healthy diet, regular exercise, and stress management can support overall well-being. Patients should carry emergency medications (e.g., epinephrine auto-injectors) if prescribed and wear medical identification indicating the condition.

When to Seek Professional Help

Seek immediate medical attention for severe allergic reactions, such as difficulty breathing, swelling, or anaphylaxis. Consult a healthcare provider for persistent or worsening symptoms, new organ involvement, or if baseline tryptase levels are elevated. Regular follow-up with a specialist (e.g., allergist, immunologist) is recommended for ongoing management.

Tips for Medical Coders

When coding for hereditary alpha tryptasemia (ICD-10-CM code D89.44), ensure documentation supports the diagnosis, including elevated baseline tryptase levels and genetic confirmation of TPSAB1 gene duplication. Note any associated symptoms or complications to accurately reflect the clinical picture. Avoid coding for unrelated conditions or triggers unless explicitly documented. Verify that the code is used for confirmed cases, as elevated tryptase alone may not be sufficient without genetic or clinical correlation.

Book a walkthrough

D89.44 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.